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ABSTRACT 
Regulatory mechanisms of malate dehydrogenase from E.coli (eMDH) 
involving NADH as an allosteric effector were investigated. The reaction was 
studied in both directions: malate oxidation and oxaloacetate reduction. When 
malate was the variable substrate, a plot of rate against substrate concentration 
was sigmoidal in the presence of 0."065 mM NADH, which indicates the presence 
of an allosteric site for NADH on the enzyme. Binding of NADH at the allosteric 
site causes conformational changes in the active site and, thereby, changes the 
catalytic activity of the enzyme. An increase in Km value, from 1.3 to 3.9 mM 
malate was observed, which indicates a decrease in the enzyme affinity for the 
substrate. 
When eMDH was chemically modified with 5'-p-flurosulfonyl-
benzoyladenosine (FSBA) in the presence of 0.15 mM NADH as a protecting 
agent, the allosteric behavior was abolished, which suggests that FSBA is 
modifying specific amino acid residues in the allosteric site and, therefore, 
preventing NADH from binding. eMDH was inactivated by FSBA in the absence 
of NADH. The inactivation appears to result from covalent modification of His 
177 in the active site, which is believed to be crucial for the catalytic mechanism 
ofeMDH. 
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Chapter I 
INTRODUCTION 
Enzymes are protein catalysts which catalyze the chemical reactions that 
take place in biological systems. Essentially, all biochemical reactions that are 
involved in metabolic pathways are enzyme-catalyzed. The rates of these 
reactions could be as much as 1012 times greater than the corresponding 
uncatalyzed reactions. 
Enzymes can be distinguished from chemical catalysts by four 
characteristic features: (1) they have higher reaction rates, (2) they function under 
relatively mild conditions of temperature, pressure, and pH, (3) they are highly 
stereospecific with respect to both substrates and products, and (4) they can be 
regulated by a number of regulatory mechanisms. 
Many enzymes catalyze reactions only in the presence of a specific non-
protein organic molecule, the coenzyrne or cofactor. Where the coenzyrne is 
required, the complete system known as the holoenzyme, consists of the protein 
(the apoenzyrne) plus the bound coenzyme. Most water soluble vitamins are 
coenzymes precursors. For example, the nicotinamide component of NAO+ and 
NADH (coenzyrnes that are involved in redox reactions) is derived from niacin, 
one of the B complex vitamins. 
In addition, enzymes display substrate saturation kinetics. In other words, 
at low substrate concentration, [S], the reaction shows a first-order dependence 
of the initial rates on [S]. However, instead of increasing indefinitely, at 
sufficiently high [S], the rate approaches a limiting value termed the maximum 
velocity, V m•x' at which there is no dependency of the rate on [S] and, therefore, 
the reaction becomes zero-order with respect to [S]. 
The concept of enzyme kinetics was developed by Michaelis and Menten 
when they proposed the mechanism of an enzyme-catalyzed reaction [1 & 2]. 
Their mechanism supposes that the first step of the reaction is the binding of the 
substrate (S) to the enzyme (E) to form an enzyme-substrate intermediate (ES). 
The second step involves the conversion of the substrate to product (P), which is 
released, with the regeneration of the free enzyme. This mechanism is presented 
in Scheme (1): 
ES kcat ---11)111o~ E+P 
Scheme (1) 
where kcat is the catalytic constant and is related to v max and the total enzyme 
concentration, [E]0, by equation (1): 
kcat [E]O = V max (1) 
The concentration of the total enzyme, [E]0, is related to the concentration of the 
free enzyme, [E], by equation (2): 
2 
[E] = [E]0 - [ES] (2) 
By applying the steady state approximation to [ES]: 
d :~S] = kl[E][S] - kcal [ES] - k_l [ES]= 0 (3) 
Substituting [E]0 - [ES] for [E] in equation (3) and solving for [ES] gives equation 
(4): 
[ES]= [E]o [S]/ {[S] + (kcal + k-i)/ kl} (4) 
Since the initial rate, v =kcal [ES], it can be expressed by inserting the expression 
for [ES] from equation (4), which gives equation (5): 
kcat [E]o [S] 
(5) V= 
[S] + ( kcat + k.1)/k1 
where (kc.1+k_1)/k1 =Km or the Michaelis constant, which is the substrate 
concentration that produces half the maximum velocity. It is also a measure of 
the affinity that an enzyme has for its substrate. The lower Km, the greater the 
affinity between the enzyme and the substrate. Therefore, equation (5) can be 
rewritten as equation (6): 
V = ( V max [S] ) / (Km + [S] ) (6) 
which is known as the Michaelis-Menten equation, which describes the 
saturation behavior that was previously discussed. 
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The regulation of enzyme activity sets them apart from non-enzyme 
catalysts. Enzyme activity can be regulated by altering the enzyme concentration, 
by the presence of inhibitors and/ or activators, by substrate availability, and by 
chemical modification. 
Allosterism is another regulatory mechanism that may control the 
catalytic activity of enzymes. Typically, an enzyme contains an active site where 
the substrate binds and initiates the chemical reaction. In addition to the active 
site, some enzymes contain another binding site, the allosteric site. Low 
molecular weight allosteric effectors (activator or inhibitor) control the catalytic 
activity of these enzymes. Binding of the allosteric molecule at the allosteric site 
causes conformational changes in the active site and therefore, changes the 
catalytic activity of the enzyme, making it higher or lower. In this case, the 
enzyme-catalyzed reaction does not follow Michaelis-Menten kinetics, which 
gives a hyperbolic plot of rate vs. [S]. Instead, a plot of rate vs. [S] is sigmoidal or 
has an "S" shape. Figure 1 shows the sigmoidal substrate saturation curve for an 
allosterically regulated enzyme in the presence of the allosteric effector. 
The sigmoidal character of a plot of v against [S] in the presence of an 
allosteric inhibitor reflects the phenomenon of cooperativity. According to Figure 
1, at low substrate concentration, the activity in the presence of the inhibitor is 
low relative to that in its absence. However, as [S] increases, the extent of 
inhibition becomes less severe. Therefore, allosterically regulated enzymes are 
more sensitive to the relative concentrations of their substrates. The kinetics are 
4 
Figure 1. 
Allosteric Behavior: Kinetic Evidence 
~llosteric effector present 
[Substrate] 
5 
consistent with the presence of two or more interacting binding sites, where the 
presence of an effector molecule at the allosteric site facilitates or inhibits the 
binding of a substrate molecule at the active site. 
Sigmoidal behavior can be described in several ways. The symmetry model of 
allosterism by Monod, Wyman, and Changeaux, which is termed MWC theory, 
is considered the most elegant model for describing cooperativity [2]. This model 
is defined by four rules: 
• An allosteric enzyme is an oligomer. 
+ The protein can exist in two conformational states, T (tense) and R (relaxed). 
These states are in equilibrium whether or not a ligand (substrate) is bound to 
the protein. 
+ The T state has a lower affinity for the ligand and, therefore, is the less active 
form. 
+ The molecular symmetry of the protein is conserved during the 
conformational changes. 
Allosteric control could be due to the change of the R/T ratio. An allosteric 
activator functions by binding to the R state and stabilizing it. An inhibitor 
functions by binding to the T state and causes the transition to the R state to be 
more difficult. 
Allosterically regulated enzymes can be divided into two categories, K-series 
and V-series [3]. For the K-series allosteric enzymes, the allosteric inhibitor 
increases the Km value and therefore, decreases the enzyme affinity for the 
6 
substrate without affecting V max· For the V-series enzymes, the inhibitor lowers 
the catalytic efficiency of the enzyme by lowering V max without affecting Km. 
As was mentioned earlier, Michaelis-Menten kinetics cannot be applied to the 
substrate saturation curve in the presence of the allosteric effector. Instead, the 
Hill equation: 
v 
Vmax - V 
= n Jog [S] - JogK (7) Jog 
was derived to describe the allosteric behavior of proteins, where K is the 
dissociation constant of the ligand. The value of "n", the slope of the equation, is 
a measure of cooperativity. If n = 1, there is no cooperativity; if n > 1, there is 
positive cooperativity. 
This project is concerned with the regulatory aspects of malate 
dehydrogenase from E.coli (eMDH). Dehydrogenases represent a class of 
enzymes that catalyze the oxidation of an alcohol to a keto-group. eMDH 
catalyzes the last step in the TCA cycle, the reversible oxidation of L-malate to 
oxaloacetate with the subsequent reduction of NAD+ to NADH, a coenzyme 
utilized by most dehydrogenases (Figure 2). Although the equilibrium of this 
reaction is in favor of malate/NAD• by a factor of 105 (L\G0 = +29.7 KJ I mol), in a 
living cell, the net flux is toward the formation of oxaloacetate because it is 
continuously removed by the first reaction of the TCA cycle, the condensation of 
OAA with acetyl-CoA to form citrate. 
7 
OH 
Mai ate 
NAD+ 
MDH 
NA~H+ 
0 
Oxaloacetate 
co-2 
Figure 2. The Reaction Catalyzed by Malate Dehydrogenase (MOH) 
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In eukaryotic organisms, MDH exists in two forms, the cytosolic and the 
mitochondrial isozymes. Cytosolic MDH participates in the aspartate/malate 
shuttle by which the cytosolic reducing equivalents are transported across the 
mitochondrial membrane. Mitochondrial MDH participates on the other side of 
the aspartate/ malate shuttle, in addition to catalyzing the formation of OAA. 
eMDH was found to be closely homologous with mitochondrial MOH. It is a 
dimeric protein that consists of two identical subunits; each with a molecular 
weight of 35 kD [4]. Kinetic studies on eMDH have indicated that it, like other 
MDH's, follows an ordered Bi Bi kinetic mechanism, in which NAD• binds first 
followed by malate and OAA is released before NADH [5 & 6]. It was also 
indicated that eMDH has a single ionizing group in the active site with a pKa 
range between 7.8 and 8.5. This ionizing group is believed to be His 177, which 
acts as a general acid/base in the catalytic mechanism of the enzyme [5]. 
In 1966, research by Kuramitsu showed that AMP, ADP, and ATP activate the 
reaction catalyzed by eMDH in the direction of NAD• reduction [7]. According to 
this observation, it is unlikely for these nucleotides to bind at the active site. It 
was also observed that AMP decreases the Km value for NAD• from 3.7 to 0.79 
mM and therefore, increases the enzyme affinity for NAD• without altering V max 
of the reaction. This work has led to the proposal of the presence of an allosteric 
site on eMDH where adenine nucleotides bind and alter the binding properties 
in the active site. 
9 
Three years later, in 1969, Sanwal presented evidence that eMOH may be 
regulated by NAOH in an allosteric manner [8]. When OAA was the variable 
substrate, Sanwal showed eMOH to be allosterically regulated in the presence of 
0.065 mM, 0.13 mM, and 0.32 mM NAOH. However, the plots of rate vs. [OAA] 
under these conditions did not clearly present the sigmoidal curve, which 
characterizes the allosteric behavior. This observation, in addition to Kuramitsu's 
data, has led to the need of further investigations regarding the allosteric effect of 
eMOH. 
The work presented here focuses on studying the allosteric behavior of 
eMOH in the presence of NAOH as the allosteric effector. The main purpose is to 
determine whether or not NAOH allosterically regulates the reaction catalyzed 
by eMOH. A kinetic tool was utilized which involved measuring the initial 
reaction rates under different concentrations of the substrate (MAL or OAA) and 
fixed concentrations of the cofactor (NAO+ or NAOH). The reaction was studied 
in both directions: NAO+ reduction and NAOH oxidation. 
Another tool utilized to study enzyme kinetics involves chemical 
modification using reagents that can covalently bind to proteins. Binding of these 
modifying reagents to specific amino acid residues that play a key role in 
catalysis alters the catalytic activity of enzymes. In this project, eMOH was 
chemically modified in order to determine the effect of this modification on the 
allosteric behavior of the enzyme. The modifying agent used was 
5'-p-flurosulfonylbenzoyladenosine (FSBA), shown in Figure 3. 
10 
N~ 
0 0 
''-0-'' F-~ " j C-01 0 
0 
Figure 3. 
The Structure of FSBA OH OH 
FSBA was selected as the modifying agent since it has been found to be 
involved in specific modification of nucleotide binding sites of a wide variety of 
enzymes. Pyruvate kinase [9] and pig heart mitochondrial MOH [10] were 
shown to be chemically modified and, therefore, inactivated by FSBA. In 
addition, FSBA has the adenosine moiety, which makes it an appropriate analog 
of NAO• and NADH (Figure 4). Previous work has shown that this moiety is 
required for recognizing the active site of the enzyme being modified [9]. 
Different mechanisms that were proposed for the modification with FSBA are 
discussed in Chapter IV. 
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0 
O=P-o· 
I 
0 
I . 
O=p-0 
I o----. 
OH 
NA[f 
2[H] 
+ H'" 
NADH+lf 
Adenosine 
OH 
Figure 4. 
The structure of NAD+ and NADH 
Another aspect of this project, unrelated to regulation, is concerned with 
strong hydrogen bonds, an interesting category of hydrogen bonds. Strong 
hydrogen bond energies are in excess of 12 kcal/mol [11], and sometimes equal 
those of covalent bonds. They have low-energy-barrier potential wells in which 
the position of the proton is variable and sensitive to the molecular environment. 
Therefore, they are referred to as low barrier hydrogen bonds (LBHB) or ionic 
hydrogen bonds. A LBHB is characterized by large infrared stretching frequency 
shifts and by relatively large downfield proton NMR chemical shifts (between 15 
and20ppm). 
12 
Hydrogen bonds are known to be involved in enzyme catalysis through 
the formation of a structure called, the "charge-relay-system" between amino acid 
residues in the active site. This structure serves to conduct electrons through the 
hydrogen bonds [12 &13]. A LBHB was found to play an important role in the 
catalytic mechanism of chympotrypsin through the formation and stabilization 
of a tetrahedral intermediate between the enzyme and the substrate [14]. 
The crystal structure of eMDH in the presence of a substrate analog citrate 
has shown that His 177 at the active site is within a hydrogen bond distance of 
Asp 150, the bound citrate, and the cofactor [15]. NMR spectroscopy was utilized 
in an attempt to investigate the hydrogen bonds within the active site and their 
role in the catalytic mechanism of eMDH. 
13 
Chapter II 
EXPERIMENT AL PROCEDURES 
+ Chemicals and Instruments: 
1. Chemicals: 
All reagents were purchased from Sigma Chemical Company. E.coli 
HB101 strain was obtained from American Type Culture Collection. Potassium 
phosphate dibasic was obtained from Aldrich Chemical Company Inc. The 
Bradford reagent and the Affi-Gel Blue agarose were obtained from Bio-Rad. 
2. Instruments: 
Centrifugation was performed on a Beckman Avanti J-30 I centrifuge at 
4°C. The sonication of E.coli cell paste was performed on a Bronwill Scientific 
Biosonik III sonicator. The enzyme assays were performed using a Simadzu UV-
3100 spectrophotometer with a thermostated microprocessor controlled cell 
holder. Stopped-flow measurements were performed using an Applied 
Photophysics Stopped-Flow Reaction Analyzer, SX-18 MV. Km and V max values 
were calculated using the software "Enzfitter" by Robin J. Leatherbarrow. The 1H 
NMR spectroscopy was performed at 300 MHz using a General Electronics QE-
300 Spectrometer. 
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• Preparation of E.coli Culture: 
The E.coli HB101 strain colonies were used to inoculate 5 mL LB medium 
that was incubated at 37° C for 18 hours with shaking at low speed in the shaker 
room. When growth was observed, the cells were tested for the presence of 
pEM6, which carries the MDH gene. This was done by using 50 µL of the 
overnight culture to inoculate 3 test tubes, each one contained 5 mL LB medium 
in addition to 50 µg I mL ampicillin (63 µL of 4 mg/ml ampicillin). The cells 
were incubated at 37° C for 18 hours with shaking. The growth of E.coli colonies 
in the presence of ampicillin indicated the presence of the pEM6 plasmid. The 
contents of the test tubes were added to 3 one-liter flasks containing 1 liter of LB 
medium, in addition to 50mg ampicillin. The flasks were incubated at 37° C for 18 
hours with shaking at low speed. The culture was centrifuged at 4,000 RPM for 
20 min at 4° C. The supernatant was decanted and discarded. The cell paste was 
collected, weighted, and frozen until needed. 
+ Enzyme Extraction and Purification: 
Approximately 0.5 g of the cell paste was thawed and mixed with 25 ml of 
10 mM potassium pohosphate (KPi) buffer pH 7.2 on ice with a magnetic stir bar. 
The solution was then sonicated on ice at 65 % of the maximum power for 60 
seconds. The solution was kept in ice for 60 seconds between sonications. This 
process was repeated 5 times. The protein extract was then centrifuged at 4,000 
15 
for 30 min at 4°C. The supernatant was assayed for activity and protein 
concentration. 
Approximately 25 ml of Affi-Gel Blue was washed with lL of 6 M urea 
solution followed by deionized water and was then equilibrated with 10 mM I<Pi 
buffer pH 7.2. The supernatant was mixed with blue agarose, and was allowed 
to stand for 15 min at 4°C. This allowed the binding of eMDH to the blue agarose. 
In the cold room, a column of the enzyme-bound blue agarose was built and 
washed overnight with 10 mM KPi buffer pH 7.2 to remove any unbound 
protein. The column was washed until the absorbance at 280 nm was less than 
0.1. The enzyme was eluted from the column using 0 tol M NaCl gradient in 10 
mM I<Pi buffer pH 7.2. Fractions of 3 ml each were collected and assayed for 
enzyme activity. The fractions that showed high activity were combined and 
assayed for activity and protein concentration. The eMDH was concentrated by 
centrifugation at 2,000 RPM at 4°C using Centriplus concentrators. The 
centrifugation was continued until the total volume was 10% of the volume of 
the combined fractions. The concentrated protein was then assayed for total 
activity and protein concentration. 
+ The Enzyme Assay in the Forward Direction (Malate Oxidation): 
Malate and NAD+ were dissolved in 50 mM TAPS buffer pH 9.0 
containing 100 mM KCl and 2 mM EDTA. The control assay was performed in 
the direction of NAD+ reduction and consisted of 7 mM NAD·, variable 
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concentrations of malate (0.15 to 12.0 mM), 50 mM TAPS buffer pH 9.0, 100 mM 
KCl and 2 mM EDTA. The reaction began with the addition of 6.7 nM active site 
MDH. The increase in the absorbance of NADH was recorded at 340 nm. In a 
separate experiment, the assay was performed in the presence of 0.18 mM NAD• 
instead of 7 mM as was stated in the literature (8). 
• The Enzyme Assay in the Reverse Direction ( OAA Reduction): 
The routine assay for enzyme activity was performed in the direction of 
NADH oxidation. Oxaloacetate and NADH were dissolved in 50 mM I<Pi buffer 
pH 7.2 containing 100 mM KCl and 2 mM EDTA. The enzyme assay contained: 
0.15 mM NADH, 0.10 mM OAA, 50 mM KPi buffer pH 7.2. The reaction was 
started by the addition of 0.01 mL of the diluted MDH. The assay was performed 
at 25°C. The decrease in NADH absorbance was recorded at 340 nm. The 
number of units was calculated according to the equation: 
MDH activity (u/mL) = (60D/min) (1/6.22) (0.01 mL) (8) 
where 6.22 mM' is the extinction coefficient of NADH at 340 nm, and 0.01 mL is 
the volume of MDH. 
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• The Allosteric Assay: 
The allosteric assay contained the same conditions as the control assay in 
the forward direction, in addition to the presence of 0.065 mM NADH as the 
allosteric effector. The assay was performed at 25°C and the increase in 
absorbance was recorded at 340 nm. 
• Protein Assay 
The protein concentration was determined using 1 mL of Bradford 
reagent, diluted 5-fold and 20 µL protein solution. The absorbance was recorded 
against reagent blank at 595 nm at 25°C and the concentration was calculated 
using the equation: 
Protein cone. (mg/ mL) = (Abs + 0.0166) I 1.1887 (9) 
The specific activity was calculated as the number of units/mg protein. 
Chemical Modification 
1) Treatment with 5'-p-flurosulfonyl benzoyl adenosine ( FSBA ): 
FSBA was dissolved in absolute ethanol. The concentration of the stock 
solution was 10 mM. The experiment was performed in the presence of NADH to 
protect the active site from binding to FSBA. Two eMDH samples were prepared: 
modified and control. The control sample consisted of: 300 nM MDH, 10% 
absolute ethanol, 0.15 mM NADH, 50 mM TAPS buffer, pH 9.0 and 100 mM KCl. 
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The modified sample contained the same concentrations except for the presence 
of 0.1 mL of 10 mM FSBA. NADH was added before the addition of FSBA. The 
two samples were incubated for 4 hours at room temperature. However, when 
the samples were assayed for enzyme activity, a significant drop of the rates was 
observed. As a result, the experiment was repeated with incubation time of one 
hour at room temperature. After the incubation period, the enzyme was washed 
using equal volume of 50 mM TAPS buffer pH 9.0 and centrifuged at 2000 RPM 
for 20 min, after being loaded in Centriplus concentrators, at 4°C in order to 
remove any unbound FSBA. The washing process was repeated 3 times. 
In order to determine the effect of the modification, 10 µL aliquots from 
the control and the modified samples were assayed in the forward direction in 
the absence and presence of 0.065 mM NADH. 
2) The Chemical Modification with FSBA without protecting the active site: 
This experiment was performed in order to determine the role of NADH 
in protecting the active site from being modified by FSBA, which in tum might 
give an idea whether the FSBA is modifying the active site or the allosteric site. 
In this experiment, two samples were prepared: protected and 
unprotected eMDH. The unprotected enzyme sample consisted of: 690 nM 
eMDH active sites, 0.1mMFSBA,50 mM TAPS buffer pH9.0. The protected 
sample contained the same concentrations in addition to the presence of 0.15 mM 
NADH. The two samples were incubated for 1 hour at room temperature and 
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washed as was described previously. The control assay in the forward direction 
was performed on both samples. 
+ Allosteric Effect using the Stopped-Flow Spectrophotometer: 
The experiment was performed in the Department of Chemistry, 
University of Illinois, Urbana-Champaign using an Applied Photophysics 
stopped-flow spectrophotometer. The stopped-flow technique allowed us to 
record the exact initial rates of the reaction. The final volume of the assay was 
100 µL. The control assay in the forward direction consisted of: variable 
concentrations of malate (from 0.043 to 8.5 mM), 0.18 mM NAD·, 50 mM TAPS 
buffer pH 9.0 and 100 mM KCL The increase in the NADH absorbance was 
recorded at 340 nm and 25° C. The rates were recorded as the change of the 
absorbance per second, which was converted to the change of the absorbance per 
minute. The allosteric assay was performed under the same conditions, in 
addition to the presence of 0.065 mM NADH as the allosteric effector. 
+ The Allosteric Effect in the direction of NADH oxidation: 
The purpose of this experiment was to determine whether or not eMDH is 
allosterically regulated in the reverse direction, NADH oxidation. The 
experiment was performed using both the conventional and the stopped-flow 
spectrophotometers. 
Both NADH and OAA were dissolved in 50 mM KPi buffer, pH 7.2. Three 
different concentrations of NADH were used: 0.017 mM, 0.15 mM, and 0.32 mM. 
The assay mixture consisted of variable concentrations of OAA (from 0.003 mM 
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to 0.16 mM), NADH concentration was fixed, SO mM KPi buffer pH 7.2 
containing 100 mM KCl, and 2 mM EDTA. The reaction was started by the 
addition of 0.8 nM eMDH (0.16 nM active sites). The decrease in absorbance was 
recorded at 340 nm and 25° C. Since the change in absorbance in the presence of 
0.32 mM NADH was very small compared to the initial absorbance, the rates 
recorded in this assay were measured against a 0.15 mM NADH blank. 
+ The Chemical Modification with FSBA at pH 7.2: 
The purpose of this experiment was to determi.r).e the effect of the chemical 
modification on the allosteric behavior of eMDH in the reverse direction. The 
enzyme was incubated with FSBA under the same conditions that were 
described above. However, 50 mM KPi buffer pH 7.2, containing 100 mM KCl, 
and 2 mM EDTA was used instead of the TAPS buffer. After the washing 
process, the enzyme was diluted and used in the enzyme assay in the presence of 
0.32 mM NADH. 
+ Protein NMR Studies: 
In order to run this experiment, high protein concentration was required. 
Therefore, two eMDH extracts were combined, concentrated and lyophilized. 
Protein Lyophlization (Freeze Drying): 
The protein solution needed to be lyophilized for two reasons: 1) to 
eliminate the water molecules, which will reduce the intensity of the water 
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signal, and 2) to achieve the highest possible protein concentration. The protein 
extract (approximately 1.9 mL) was frozen, in a 25 mL round bottom flask, using 
liquid nitrogen and was then dried under vacuum for 3 to 4 hours or until all the 
solution was converted to a white powder. The dry protein was then 
reconstituted in 0.6 mL D20. At this point, there was some protein left that could 
not be dissolved after swirling the solution on ice for approximately 15 min. As a 
result, the protein solution was centrifuged at 3,000 RPM for 20 min at 4°C. The 
supernatant was assayed for activity and protein concentration. 
'H NMR Experiment: 
The NMR spectra were recorded for the lyophilized protein with DSS as 
an internal standard. The protein concentration was approximately 0.1mMin0.6 
mL D20. The sweep width was 1000 ppm. In the first spectrum, the number of 
acquisitions was 496 and D5 (relaxation time) was 1.5 sec. In order to improve 
the signal-to-noise ratio, the second spectrum was obtained using 10512 
acquisitions and D5 was 1.5 sec. All spectra were collected at 21°C. 
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Chapter III 
RESULTS 
• Purification of Malate Dehydrogenase: 
Enzyme activity and protein concentration for the crude and purified 
MDH are summarized in Table 1. 
Table 1: Results of MDH purification. 
Total Units Protein Cone. Specific Activity 
(mg/ mL) (unit/ mg) 
After 5082.5 1.7 199.6 
Extraction 
After 1686.6 0.042 787.4 
Purification 
After 1656.5 0.54 808.S 
Concentration 
• The Allosteric Assay: 
In this experiment, malate concentration was varied from 0.15 to 12.0 mM, 
NAD• and NADH concentrations were held constant at 7 mM and 0.065 mM 
respectively. The buffer used was 50 mM TAPS pH 9.0containing100 mM KCL 
The data from the control and the allosteric assays is summarized in Table 2, and 
the plot of the rate vs. malate concentration is presented in Figure 5. 
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Table 2. The allosteric effect of eMDH in the presence of 0.065 mM NADH 
Conditions: 0.15to12.0 mM malate, NAD• was fixed at 7 mM, NADH was 
fixed at 0.065 mM, 50 mM TAPS pH 9.0 and 100 mM KCl 
Malate cone. Rate (~OD/min) Rate (~OD I min) 
(mM) Control With 0.065 mM NADH 
0.15 0.060 0.003 
0.5 0.110 0.004 
1.0 0.143 0.007 
2.0 0.180 0.050 
3.0 0.201 0.062 
5.0 0.220 0.075 
7.0 0.260 0.090 
10.0 0.276 0.096 
12.0 0.286 0.120 
The sigmoidal curve in the presence of 0.065 mM NADH that is shown in 
Figure 5 supports the proposal of the presence of an allosteric site where NADH 
binds and changes the catalytic activity of eMDH. 
• The Chemical Modification with FSBA: 
The chemical modification experiment was performed to determine 
whether or not FSBA will covalently bind to the allosteric site and affect the 
binding of NADH at this site. The enzyme was incubated with 1 mM FSBA in the 
presence of 0.15 mM NADH to protect the active site from being modified . Both 
the control and the allosteric assays were performed on the control and the 
modified enzyme. Tables 3 & 4 list the results of the control and the allosteric 
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Figure 5. 
A plot of the rate vs. [malate] in the absence and presence of 0.065 mM 
NADH showing the allosteric behavior of eMDH 
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assays for both the control and the modified eMDH respectively. The plots of this 
data are presented in Figures 6 & 7. 
Table 3. Chemical Modification with FSBA 
Control eMDH (not treated with FSBA) 
Conditions: 7 mM NAD+, 0.15 to 12.0 mM malate, 0.065 mM NADH, 50 mM 
TAPS pH 9 .0 and 100 mM KCl 
Malate cone. (mM) Control Rate (60D/min) Rate ( 60D/min) 
with 0.065 NADH 
0.15 0.023 0.0005 
0.5 0.030 0.0006 
1.0 0.043 0.0017 
2.0 0.054 0.0077 
3.0 0.060 0.0129 
5.0 0.073 0.0210 
7.0 0.081 0.0226 
10.0 0.080 0.0225 
12.0 0.081 0.0225 
Table 4. Chemical Modification with FSBA 
Modified eMDH (treated with FSBA) 
Conditions: 7 rnM NAD+, 0.15to12.0 mM malate, 0.065 mM NADH, 50 mM 
TAPS buffer pH 9.0 and 100 mM KCI 
Malate cone. (rnM) Control Rate (60D/rnin) Rate ( 60D/min) 
With 0.065 NADH 
0.15 0.008 0.005 
0.5 0.013 0.007 
1.0 0.016 0.009 
2.0 0.020 0.015 
3.0 0.025 0.018 
5.0 0.034 0.020 
7.0 0.040 0.021 
10.0 0.041 0.020 
12.0 0.041 0.020 
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Chemical Modification with FSBA 
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Figure 6. 
12.0 14.0 
Plot of rate vs. [MAL] in the absence and presence of NADH for the 
control eMDH that was not treated with FSBA 
Conditions: 0.15 to 12.0 mM Malate, 7 mM NAO+, 0.065 mM NADH, 
and 50 mM TAPS buffer pH 9.0 
27 
Chemical Modification with FSBA 
Modified eMDH 
0.045 ...----------------------------. 
Control Control 
0.040 Km = 2.2 mM ± 0.5 (2.2.7%) • 
0.035 
0.030 
Q) 0.025 
With 0.065 mM NADH 
-CU 
a: 0.020 • • 
0.015 
0.010 
0.005 
With 0.065 mM NADH 
Km = 1.08 ± 0.22 (20.7%) 
Vmax = 0.02 ± 1.2 E-03 (6%) 
0.000 ---------------.----------.--------
0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 
[malate] (mM) 
Figure 7. 
Plot of rate vs. [MAL] in the absence and presence of NADH for the 
modified eMDH that was treated with FSBA 
Conditions: 0.15 to 12.0 mM malate, 7 mM NAO+, 0.065 mM NADH, and 
50 mM TAPS buffer pH 9.0 
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The eMDH sample that was treated with FSBA did not show the allosteric 
behavior in the presence of 0.065 mM NADH, which suggests that FSBA may 
have covalently modified a specific amino acid residue at the allosteric site and, 
therefore, prevented the binding of NADH. 
However, the data obtained from the allosteric assay in the presence of 
NADH (Figure 5) was not reproducible when the assay was repeated several 
times in order to confirm this behavior. 
In addition, the control and the allosteric assays were also performed in 
the presence of 0.18 mM NAD• as was stated in the literature instead of 7 mM [8]. 
Each data point of the assay in the presence of NADH was repeated three times 
and the average was considered as the actual rate. Tables 5 & 6 list the results of 
this assay. A p lot of this data is presented in Figure 8. 
Table 5. The control assay using 0.18 mM NAD• 
Malate cone. (mM) Control Rate (~OD/min) 
0.15 0.0030 
0.5 0.0119 
1.0 0.0235 
2.0 0.0365 
3.0 0.0501 
5.0 0.0573 
7.0 0.0721 
10.0 0.0755 
12.0 NA 
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Table 6. Results from the allosteric assay at 0.18 mM NAD+ and 0.065 
mM 
[malate] Rate Rate Rate Average 
(mM) (LiOD/min) (LiOD/min) (LiOD/min) rate 
Trial# 1 Trial# 2 Trial# 3 
0.15 0.0004 NA 0.0004 0.0004 
0.5 0.0051 0.0070 0.0037 0.0053 
1.0 0.0067 0.0126 0.0069 0.0087 
2.0 0.0145 0.0199 0.0177 0.0174 
3.0 0.0186 0.0224 NA 0.0205 
5.0 0.0289 0.0365 0.0335 0.0329 
7.0 0.0346 0.0367 NA 0.0357 
10.0 0.0394 NA 0.0361 0.0378 
12.0 NA NA 0.0420 0.0420 
As Figure 8 shows, the allosteric effect could not be detected using 0.18 
mM NAD+. At this point, it was not clear whether or not eMDH is allostericaly 
regulated by NADH. The fact that this behavior was observed in the first set of 
data led to the idea of using a different technique to record the initial rates of the 
reaction. 
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Figure 8. 
Plot of rate vs. [MAL] using 0.18 mM NAO+ in the absence and the 
presence of 0.065 mM NAOH 
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14.0 
• The Enzyme Assay using the Stopped-Flow Spectrophotometer: 
The assay was performed using an Applied Photophysics stopped-flow 
spectrophotometer, which allowed us to record the exact initial rates of the 
reaction. In this experiment, lower concentrations of malate were used, varying 
from 0.04 to 8.5 mM. NAD+ and NADH concentrations were held constant at 0.18 
mM and 0.065 mM respectively. The rates were recorded as LiOD I sec., which 
was converted to LiOD I min. Table 7 shows the rates of the reaction from the 
control and the allosteric assays. A plot of v against [malate] is presented in 
Figure 9. 
Table 7. The rates obtained from the control and the allosteric assays 
using the stopped-flow spectrophotometer. 
Conditions: 0.0425 to 8.5 mM malate, 0.18 mM NAD+, 0.065 mM NADH, 
and 50 mM TAPS pH 9.0. 
Malate cone. (mM) Rate (LiOD/min), Rate (LiOD/min), 
Control WI 0.065 mM NADH 
0.0425 0.0245 0.0047 
0.085 0.0647 0.0101 
0.213 0.1080 0.0219 
0.425 0.1790 0.0476 
0.850 0.4143 0.0795 
1.70 0.800 0.1581 
3.0 1.0448 0.3684 
4.25 1.5190 0.6230 
8.5 1.8280 0.6871 
As Figure 9 shows, using lower concentrations of malate allowed the 
detection of the allosteric effect of eMDH at 0.18 mM NAD·. The data obtained 
from this assay were fit to the Hill equation and "n" value of 1.2 was obtained. 
Figure 10 shows a plot of log v /V m •• -v against log [S]. 
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Figure 9. 
Plot of rate vs. [MAL] using the stopped-flow spectrophotometer. 
Conditions: 0.0425 to 8.5 mM malate, 0.18 mM NAO+, 0.065 mM NADH, 
and 50 mM TAPS buffer pH 9.0 
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34 
• The Chemical Modification with FSBA, using 0.18 mM NAD• in the 
enzyme assay: 
The enzyme was incubated with FSBA under the same conditions that 
were described previously. Tables 8 & 9 list the rates that were obtained from the 
enzyme assays using the control and modified eMDH respectively. Figure 11 
represents the control and the allosteric assays for the control eMDH (was not 
treated with FSBA) with the sigmoidal curve in the presence of 0.065 mM 
NADH. However, as Figure 12 shows, the FSBA did not completely block the 
allosteric site, since the plot of the enzyme assay in the presence of NADH does 
not follow Michaelis-Menten equation. 
Since this behavior might be due to the incomplete substrate saturation of 
eMDH at low concentration of NAD·, the enzyme assays were performed on the 
same samples of eMDH using 7 mM NAD·. This data is presented in Tables 10 
and 11. As figures 13 and 14 show, eMDH did not exhibit the allosteric effect 
after being modified with FSBA. 
35 
Table 8. Chemical Modification with FSBA 
Control eMDH that was not treated with FSBA 
Conditions: 0.05 to 10.0 mM malate, 0.18 mM NAO·, 0.065 mM 
NADH and 50 mM TAPS oH 9.0 
Malate cone. (mM) Rate ( 600 I min) Rate ( 600 I min) 
Control With 0.065 mM NADH 
0.05 0.005 0.002 
0.10 0.009 0.003 
0.25 0.019 0.004 
0.5 0.032 0.004 
1.0 0.048 0.013 
2.0 0.086 0.023 
5.0 NA 0.030 
10.0 0.107 0.033 
Table 9. Chemical Modification with FSBA 
Modified eMDH that was treated with FSBA 
Conditions: 0.05 to 10.0 mM malate, 0.18 mM NAO·, 0.065 mM 
NADH and 50 mM TAPS pH 9.0 
Malate cone. (mM) Rate (60D/min) Rate (60D I min) 
Control With 0.065 mM NADH 
0.05 0.003 0.0015 
0.10 0.006 0.0035 
0.25 0.011 0.0055 
0.5 0.026 0.008 
1.0 0.043 0.012 
2.0 NA 0.026 
5.0 0.084 0.039 
10.0 0.092 0.039 
36 
Q) 
Chemical Modification with FSBA Using 0.18 mM NAO+ 
in the Enzyme Assay 
Control eMDH 
0.12 ......-----------------------------. 
0.10 
0.08 
Km= 1 .3 mM ± 0.23 (16.7%) 
Vmax = 0 .12 ± 8.1 E-03 (6.7%) 
• 
Control 
~ 0.06 
a: 
0.04 With 0.065 mM NADH 
0.02 
0.00 ----.....----~-----.----"-'T"------.-----
0.0 2.0 4.0 6.0 
[malate] (mM) 
Figure 11. 
8.0 10.0 
Plot of rate vs. [malate] in the absence and presence of NADH for the 
control eMDH that was not treated with FSBA 
12.0 
Conditions: 0.05 to 10.0 mM malate, 0.18 mM NAO+, 0.065 mM NADH and 
50 mM TAPS pH 9.0 
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Plot of rate vs. [malate] in the absence and presence of NADH for the 
modified sample that was treated with FSBA. 
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Conditions: 0.05 to 10.0 mM malate, 0.18 mM NAO+, 0.065 mM NADH and 
50 mM TAPS pH 9.0 
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Table 10. Chemical Modification with FSBA 
Control eMDH that was not treated with FSBA 
Conditions: 0.05to10.0 mM malate, 7 mM NAD•, 0.065 mM 
NADH, and 50 mM TAPS pH 9.0 
Malate cone. (mM) Rate (LiOD/min) Rate (LiOD/ min) 
Control With 0.065 mM NADH 
0.05 0.018 0.001 
0.10 0.051 0.0025 
0.25 0.115 0.0038 
0.50 0.147 0.009 
1.00 0.200 0.042 
2.00 0.211 0.058 
5.00 0.222 0.101 
10.00 NA 0.125 
Table 11. Chemical Modification with FSBA 
Modified eMDH that was treated with FSBA 
Conditions: 0.05 to 10.0 mM malate, 7 mM NAD·, 0.065 mM 
NADH, and 50 mM TAPS pH 9.0 
Malate cone. (mM) Rate (LiOD I min) Rate (LiOD/ min) 
Control With 0.065 mM NADH 
0.05 0.018 0.006 
0.10 0.031 0.011 
0.25 0.069 0.031 
0.50 0.104 0.047 
1.0 0.149 0.080 
2.0 0.167 0.101 
5.0 0.170 0.128 
10.0 0.180 0.137 
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Plot of rate vs. [malate] for the control eMDH that was not treated with FSBA 
Conditions: 0.05 to 10.0 mM malate, 7 mM NAO+, 0.065 mM NADH, and 50 
mM TAPS buffer pH 9.0 
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+ Chemical Modification with FSBA without protecting the active site: 
This experiment was performed in order to determine the role that NADH 
plays in protecting the active site from being modified by FSBA. The unprotected 
MDH sample in this experiment consisted of: 1 mM FSBA in absolute ethanol, 
690 nM eMDH, and 50 mM TAPS buffer pH 9.0. The protected enzyme sample 
contained the same components, in addition to the presence of 0.lSmM NADH. 
The results of this experiment are summarized in Table 12, and a plot of rate vs. 
[malate] is presented in Figure 15. 
Table 12. Rate data from the chemical modification with FSBA without 
protecting the active site with NADH 
Conditions: 0.05 to 5.0 mM malate, 7 mM NAD•, 50 mM TAPS pH 9.0 
containing 100 mM KCl 
Malate cone. (mM) Rate (~OD/min) Rate (LlOD I min) 
protected eMDH unprotected eMDH 
0.05 0.018 0.005 
0.1 0.036 0.010 
0.25 0.072 0.022 
0.5 0.089 0.030 
1.0 0.105 0.055 
2.0 0.147 0.066 
5.0 0.153 0.075 
As the data and Figure 15 show, there was approximately 50-60 % drop in 
the catalytic activity when NADH was not added to the incubation mixture. This 
data suggests that, in the presence of NADH, FSBA might be modifying a 
specific amino acid residue in the allosteric site since the drop in rates was not 
observed in the chemical modification experiment. 
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Plot of rate vs. [malate] of FSBA-modified eMDH with and without protecting th 
active site. 
Conditions: 0.05 to 5.0 mM malate, 7 mM NAO+, and 50 mM TAPS pH 9.0 
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• The allosteric effect in the reverse direction: 
The allosteric assay was performed in the direction of NADH oxidation. 
Three different concentrations of NADH were used: 0.017 mM, 0.15 mM, and 
0.32 mM. OAA concentration was varied from 0.003 to 0.16 mM. The enzyme 
assays in the presence of 0.017 and 0.15 mM NADH were performed using the 
stopped-flow spectrophotometer. The 0.32 mM NADH assay was performed on 
the Shimadzu UV-3100 spectrophotometer, using 0.15 mM NADH as blank. 
Table 13 shows the data obtained from the three enzyme assays. Figure 16 shows 
the plots of rate vs. [OAA] using 0.017 and 0.15 mM NADH. Double reciprocal 
plot of this data is presented in Figures 17a and 17b. 
Table 13. Rate data in the reverse direction. 
Conditions: OAA was varied from 0.003 to 0.16 mM, NADH was fixed at 
0.017, 0.15 and 0.32 mM, 50 mM Kpi buffer '.)H 7.2 
OAAconc. Rate (~OD/min) Rate (~OD/min) Rate (~OD/min) 
(mM) 0.017 mM NADH 0.15mMNADH 0.32mMNADH 
0.003 0.0139 NA NA 
0.005 0.0166 0.028 0.042 
0.01 0.026 0.040 0.052 
0.02 0.031 0.063 0.065 
0.03 0.034 0.080 0.107 
0.05 0.038 0.097 0.166 
0.08 0.037 0. 121 0.198 
0.16 NA 0.122 0.20 
44 
Q) 
-ell 
er 
The Enzyme Assay in the Reverse Direction ( OAA Reduction) 
0.14 
0.15 mM NADH 
0.12 • 
0.1 
0.08 
0.06 
0.017 mM NADH 
0.04 
• 
0.02 
0 
0 0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16 0.18 
[OAA] (mM) 
Figure 16. 
Plot of rate vs. [OAA] in the reverse direction in the presence of 0.017 and 
0.15 mM NADH 
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Double Reciprocal Plot of the Enzyme Assay in the Reverse Direction 
Figure 17a. 
1/v vs. 1/[0AA] in the presence of 0.017 mM NADH 
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Figure 17b. 
1/v vs. 1 /[OAA] in the presence of 0.15 mM NADH 
Km= 0.03 mM ± 3.4 E-03 (10%) 
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Figure 17. 
A plot of 1/v vs. 1/[0AA] in the presence of a) 0.017 mM, 
and b) 0.15 mM NADH 
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As noted in Figure 16, at 0.017 mM and 0.15 mM NADH the plots of the 
rates against [OAA] are hyperbolic and follow Michaelis-Menten kinetics with 
Km values of 0.01 mM and 0.03 mM OAA, respectively (Figures 17a and 17b). 
However, the hyperbolic curve becomes sigmoidal in the presence of 0.32 mM 
NADH (Figure 18), which suggests that at a higher concentration, NADH 
allosterically regulates the catalytic activity of eMDH in the direction of OAA 
reduction. The Hill constant in this direction is 1.6 and the Km value is 0.025 mM 
OAA (Figure 19). 
+ FSBA-modified enzyme activity in the reverse direction at pH 7.2: 
This experiment was performed to examine whether the FSBA-modified 
enzyme will exhibit the same behavior in the reverse direction as the forward 
direction. The rates recorded in this experiment are summarized in Table 14. A 
plot of this data is presented in Figures 20a and 20b. 
Table 14. Rate data from the FSBA-modified eMDH at pH 7.2 
Conditions: variable concentrations of OAA, 0.32 mM NADH, 50 mM 
KPi buffer pH 7.2 containg 100 mM KCl and 2 mM EDTA 
OAA cone. (mM) Rate (~OD I min) Rate (~OD I min) 
Control eMDH Modified eMDH 
0.005 0.032 0.026 
0.01 0.043 0.035 
0.02 0.055 0.053 
0.03 0.095 0.093 
0.05 0.103 0.097 
0.08 NA 0.10 
0.16 0.102 0.110 
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Figure 18. 
Plot of rate vs. [OAA] in the reverse direction, in the presence of 
0.32mMNADH 
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Plot of rate vs. [OAA] of FSBA-modified eMDH at pH 7.2 
Conditions: 0.005 to 0.16 mM OAA, 0.32 mM NADH, and 50 mM KPi 
buffer pH 7.2 
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As Figures 20a and 20b show, the allosteric effect of eMDH in the reverse 
direction seems to be unclear. The sigmoidal plot of rate vs. [OAA] of the control 
enzyme sample that was not treated with FSBA is not as distinct as the first assay 
(Figure 18). The fact that the reaction is much faster in this direction makes the 
detection of the initial rates using the UV-3100 Shimadzu spectrophotometer not 
reliable, particularly at low OAA concentrations. The enzyme assay at 0.32 mM 
NADH was performed using the stopped-flow spectrophotometer. However, the 
plots of absorbance vs. time were noisy since a blank of 0.15 mM NADH was not 
used and the change of absorbance was very small at low [OAA]. 
+ The results of protein lyophilization: 
The routine enzyme assay in the reverse direction was used to determine 
the effect of the lyophilization procedure on the specific activity of eMDH. The 
lyophilized protein was reconstituted in 0.6 mL D20. Table 15 shows a summary 
of this data. 
Table 15. Effect of lyophilization on eMDH 
eMDH Protein Specific Activity 
concentration concentration (u/ mg) 
(u/mL) (mg/mL) 
Before 3870 3.5 1105 
lyophilization 
First treatment 6917 6.9 1002 (90.1 %) 
Second treatment 2714 4.1 662 (66.1%) 
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• 
1H NMR spectra: 
1H NMR spectra were recorded using the lyophilized protein. The first 
spectrum that was recorded using 496 acquisitions at 2fC (Figure 21) showed a 
very intense water peak, which did not allow the detection of other peaks in the 
spectrum. Therefore, the protein was relyophilized and reconstituted in 0.6 mL 
fresh D20 to minimize the exchange of deuterium with protons. The second 
spectrum was recorded using 10512 acquisitions to improve the signal-to-noise 
ratio. However, this did not reduce the intensity of the 18iO peak (Figure 22). A 
water suppression technique in order to subtract the 1H20 signal needs to be used 
in this experiment, which will allow the observation Qf the other proton signals. 
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Figure 21 
1H NMR spectrum of eMDH in D20 
The experiment was carried out using 496 acquisitions at 25·c 
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Figure 22 
IH spectrum of eMDH in D20 
The experiment was performed using 10512 acquisitions at 2s·c 
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Chapter IV 
Discussion 
The data presented in this research supports the proposal that eMDH is 
allosterically regulated by NADH in the direction of NAD• reduction. Other 
nucleotides including ATP, ADP, and AMP were found to bring about the same 
effect [7]. However, the high concentration required for this effect makes it 
unlikely that they are involved in the regulation of eMDH in vivo. 
+ Allosteric Effect in the forward direction: 
When malate was the variable substrate in the presence of 0.065 mM 
NADH, a plot of v against [MAL] resulted in a sigmoidal curve, which reflects 
the allosteric behavior of eMDH (Figure 5). These results suggest that eMDH has 
an allosteric site, which is different from the active site, where NADH and 
possibly the other nucleotides bind and change the catalytic activity of the 
enzyme. 
Since a plot of absorbance vs. time at low substrate concentration is linear 
for only few seconds, the rates recorded on the Shimadzu spectrophotometer 
might not be the actual initial rates. This might result in misinterpreting the data 
with respect to the allosteric effect since the recorded rates will be lower that the 
actual initial rates. Therefore, the experiment was repeated using the stopped-
flow spectrophotometer, in addition to using lower concentrations of the 
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substrate (MAL). This data has further supported the proposal of the allosteric 
behavior of eMDH, since a sigmoidal curve was obtained in a plot of rate vs. 
[MAL] (Figure 9). Both the stopped-flow and the conventional techniques seem 
to be comparable, as far as the forward direction is concerned, since using lower 
concentrations of MAL resulted in a sigmoidal curve. 
An interpretation of this data according to the MWC theory could be 
based on the following suggestions: 
1. Binding of NADH at the allosteric site causes conformational changes in the 
subunits and, therefore, changes the catalytic properties of the active site. This 
assumption is based on the observed increase of Km value (from 1.3 to 3.9 mM 
malate), which indicates a decrease in the enzyme affinity for the substrate. 
2. Based on the MWC model, NADH seems to preferentially bind to the T state 
of eMDH and, thereby, increases the T /R ratio by inhibiting the transition to 
the R state. 
3. Since NADH is a product of the reaction in this direction, product inhibition, 
in addition to the allosteric inhibition was observed. This explains the drop of 
V max that accompanied the increase of Km. 
4. A Hill constant value of 1.2 was obtained when v /V m•x -v was graphed against 
log [MAL ], which suggests the presence of positive cooperativity between the 
allosteric and the active sites. 
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• The Chemical Modification at pH 9.0: 
FSBA was utilized as an analog of NAD•, NADH, ATP, and ADP in 
modifying the binding sites of these nucleotides in several enzymes. This 
compound is believed to chemically modify specific amino acid residues, 
including tyrosine, histidine, lysine, serine, and cysteine [16]. The sulfonyl 
fluoride is the reactive functional group, which acts as an electrophile that is 
attacked by these amino acids. 
The modification process can take place by different mechanisms. 
Tyrosine and lysine covalently react with FSBA to yield stable derivatives [10]. 
When these derivatives were treated with 6 M HCl, the ester linkage between the 
benzoyl and the nucleoside moieties was cleaved, producing two acid-stable 
compounds, N-(4-carboxybenzenesulphonyl) lysine and 
0-(4-carboxybenzenesulphonyl) tyrosine. These two compounds are 
characterized by their hydophobicity and a net negative charge at neutral pH. A 
proposed mechanism for this type of modification is presented in Scheme 2 
where Nu· represents the amino acid residue that is being modified and R is the 
adenosine moiety. 
IT-Q-IT t~ ~ j c-oR 
Nu· 
IT-Q-IT Nu-~ ~ ;} c-oR + F · 
0 
Scheme 2. 
A proposed mechanism for the covalent modification with FSBA 
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Another mechanism that does not involve covalent modification by FSBA 
involves the formation of a disulfide between two adjacent cysteine residues. 
This mechanism is believed to be involved in the FSBA-modified 
S-adenosylhomcysteinase since the inactivation was linearly related to the loss of 
sulfhydryl groups but none of the FSBA was covalently bound to the enzyme 
[17]. 
eMDH was treated with FSBA in order to determine whether this 
modification will affect the allosteric behavior of the enzyme. The results from 
these experiments suggest that, in the presence of 0.15 mM NADH as a 
protecting agent, FSBA may modify a specific amino acid at the allosteric site 
since the allosteric behavior was abolished (Figures 7 & 14). Since modification 
with FSBA is specific to tyrosine, histidine, lysine, cysteine, and/ or serine, this 
data implies that one or more of these amino acids may be involved in binding of 
NADH at the allosteric site. When eMDH was treated with FSBA in the absence 
of NADH, approximately 50 % of the enzyme activity was lost (FigurelS). This 
observation indicates that NADH protects the active site against the inactivation 
byFSBA. 
Although the FSBA-modified eMDH did not exhibit the allosteric effect in 
the presence of NADH, it is not clear from this data whether FSBA is modifying 
the putative allosteric site or other amino acid residues that might interact with 
this site. Further experiments with respect to this modification may involve 
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analyzing the modified eMDH using an amino acid analysis technique to 
identify the residues that are modified by FSBA. In addition, incorporation of 
radioactive FSBA can be utilized in determining the stoichiometry of the reaction 
between the enzyme and the modifying agent. 
• The Allosteric Effect in the reverse direction: 
An allosteric effect in the direction of OAA reduction was observed at 0.32 
mM NADH (Figure 16), with a Hill constant of 1.6 (Figure 17). In contrast to 
Sanwal's observation (the rates were measured using a Gilford 2000 recording 
spectrophotometer) [8], the rates recorded on the stopped-flow 
spectrophotometer at 0.15 mM NADH when OAA was the variable substrate 
were not sigmoidal, but instead followed Michaelis-Menten kinetics with Km 
value of 0.03 mM OAA (Figure lSb ). 
• The Chemical modification at pH 7.2: 
eMDH was incubated with FSBA at pH 7.2 in order to determine whether 
the modified enzyme will exhibit the same behavior in the reverse direction as in 
the forward direction. However, the sigmoidal curve in the presence of 0.32 mM 
NADH when OAA was the variable substrate (Figure 17a) was not as clear as 
data presented in Figure 16. Therefore, it could not be confirmed whether NADH 
allosterically regulates the reaction catalyzed by NADH in the reverse direction. 
Since the reaction rates are much faster in this direction, and in the presence of 
0.32 mM NADH, the change in absorbance is very small particularly at low OAA 
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concentrations, obtaining the initial reaction rates using the routine 
spectrophotometers might not be reliable. 
+ Protein Lyophilization and 1H NMR data: 
The results obtained from the activity and protein assays of the 
lyophilized protein indicates that eMDH is stable under the conditions of 
lyophilization since only 10 % of the specific activity was lost. However, when 
the protein was relyophilized, the loss of the activity became more severe (34%). 
The 1H NMR spectra did not reveal any signals that might be significant 
because of the intensity of 1HiO signal. Applying a water suppression technique 
seems to be important in this experiment particularly at low protein 
concentration. 
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